1.Single B cell monoclonal antibody technologies and applications.
Xiangyang CHI ; Changming YU ; Wei CHEN
Chinese Journal of Biotechnology 2012;28(6):651-660
Monoclonal antibodies (mAbs) contribute a lot to the development of numerous fields in life science as a pivotal tool in modern biological research. Development of the PCR methods and maturation of antibody production have made it possible to generate mAbs from single human B cells by single cell RT-PCR with successional cloning and expression in vitro. Compared to traditional monoclonal antibody technologies, single B cell technologies require relatively fewer cells, which are highly efficient in obtaining specific mAbs in a rapid way with preservation of the natural heavy and light chain pairing. With so many advantages, single B cell technologies have been proved to be an attractive approach for retrieval of naive and antigen-experienced antibody repertoires generated in vivo, design of rationale structure-based vaccine, evaluation and development of basic B cell biology concepts in health and autoimmunity, and prevention of infectious diseases by passive immunization and therapy for disorders. Accordingly, this review introduced recent progresses in the single B cell technologies for generating monoclonal antibodies and applications.
Antibodies, Monoclonal
;
biosynthesis
;
genetics
;
immunology
;
Antibody Specificity
;
B-Lymphocytes
;
cytology
;
immunology
;
metabolism
;
Humans
;
Immunologic Techniques
2.The preparation of monoclonal antibodies against AAV2 and study on their characterizations.
Shu-Ping TAN ; Zhen-Hua YUAN ; Wen-Hong TIAN ; Xiao-Yan DONG ; Xiao-Bing WU
Chinese Journal of Virology 2009;25(4):267-273
7 strains of stable cell lines secreting monoclonal antibodies against AAV2 capsids were obtained by immunizing BALB/C mice with highly purified recombinant adeno-associated virus. Among them, the monoclonal antibodies B10 and G4 had neutralizing activity, and their subtypes were IgG1 and IgG2a, respectively. The binding characterizations of the two neutralizing antibodies were studied. Both B10 and G4 showed serotype specific binding activities to rAAV2 virus particles other than AAV1, AAV5, and AAV8, and the binding could not be blocked by heparin. After incubating with the two antibodies separately, rAAV2 viruses could still bind to sensitive cell line BHK-21, suggesting that the binding sites of the two antibodies to rAAV2 located at different positions on viral particle surface from the primary receptor binding sites of AAV2. Western blotting assay showed that B10 could bind to VP1, VP2 and VP3 of rAAV2. However, G4 bound none of them. The results suggested that B10 recognized a linear epitope of AAV2 capsid, whereas G4 probably recognized a conformational epitope on the surface of AAV2 virus particle. The two antibodies with different characteristics provided valuable tools for AAV2 virus particles detection and infection processes.
Animals
;
Antibodies, Monoclonal
;
immunology
;
Antibodies, Viral
;
immunology
;
Antibody Specificity
;
Capsid
;
immunology
;
Cell Line
;
Dependovirus
;
genetics
;
immunology
;
Epitopes
;
immunology
;
Female
;
Humans
;
Immunoglobulin G
;
immunology
;
Mice
;
Mice, Inbred BALB C
3.Research Progress in the F Gene and Protein of the Respiratory Syncytial Virus.
Chinese Journal of Virology 2015;31(2):201-206
The respiratory syncytial virus (RSV) belongs to the family Paramyxoviridae and subfamily Pneumovirinae. The RSV can cause acute infections of the lower respiratory tract in infants. The F gene of the RSV is a conservative gene and varies only slightly in its expression. Few studies focusing on the variability of the F gene have been carried out. F protein (fusion glycoprotein) is a transmembrane glycoprotein that mediates fusion and penetration between the virus and host cells. Neutralizing antibody against the F protein can protect against infection by RSV subtypes A and B. Hence, F protein has become the main target for the development of a monoclonal antibody and vaccine against the RSV. An effective vaccine is not available, so a monoclonal antibody against F protein is now the most important method to reduce the morbidity and severity associated with RSV infection in high-risk children. However, a monoclonal antibody can lead to the production of drug-resistant strains of the RSV. This review focuses on genetic variation of the F gene of the RSV as well as progress in the development of a monoclonal antibody against F protein and a vaccine in the last decade.
Animals
;
Antibodies, Monoclonal
;
immunology
;
Humans
;
Respiratory Syncytial Virus Infections
;
immunology
;
prevention & control
;
virology
;
Respiratory Syncytial Viruses
;
genetics
;
immunology
;
Viral Fusion Proteins
;
genetics
;
immunology
;
Viral Vaccines
;
genetics
;
immunology
4.Preparation and verification of antibodies for five rice receptor-like kinases.
Bo WANG ; Liyun LI ; Yinghao CAO ; Ziguang LIU ; Guozhen LIU
Chinese Journal of Biotechnology 2010;26(6):796-801
Receptor-like kinase involves self-incompatibility, male sterility, stress responses, and disease resistance. To better understand the physiological function and biological characteristics of rice receptor-like kinase, we cloned five predicted epitope fragments of rice receptor-like kinase. The purified fusion protein was used as antigen to immunize rabbit to get specific polyclonal antibodies. Western blotting analysis shows that the five receptor-like kinases were expressed in rice leaves.
Animals
;
Antibodies, Monoclonal
;
biosynthesis
;
immunology
;
Cloning, Molecular
;
Epitopes
;
immunology
;
Immunization
;
Oryza
;
enzymology
;
genetics
;
Plant Proteins
;
genetics
;
immunology
;
Plantibodies
;
immunology
;
metabolism
;
Protein Kinases
;
genetics
;
immunology
;
Rabbits
5.Isolation of single chain antibodies against cell surface molecules by pathfinder selection.
Jun-xia LIU ; Lei MENG ; Jing XU ; Hai-rong JIA ; Zeng-xuan SONG
Acta Academiae Medicinae Sinicae 2004;26(4):405-409
OBJECTIVETo isolate single chain antibody fragments (scFv) against cell surface molecules by pathfinder selection from an anti-KG1a cell scFv phage library.
METHODSThe anti-KG1a scFv library was enriched by KGla cell panning for three rounds, or unenriched, then processed for pathfinder selection respectively using anti-CD34 monoclonal antibody as pathfinder molecule. ScFv phage clones were randomly picked and identified by binding KG1a cells using immunofluorescein and flow cytometry. The KG1a+ clones were further identified by KG1a, HL60, U937, and CEM cell lines and ELISA. Their antigenic molecules on cell surface were digested by chymopapain and analyzed by flow cytometry. DNAs from ten positive clones were sequenced. The scFv clones with different primary structure were used to analyze the molecular weight of their antigens by Western blot.
RESULTSOne hundred and two KG1a+ scFv phage clones were isolated from 144 enriched and 96 unenriched scFv phage library respectively, among which 47 bound KG1a, HL60, U937, and CEM cells, 55 bound KG1a cells exclusively. None of 28 KG1a+, HL60-, U937-, and CEM- scFv clones bound to the CD34 antigen, as confirmed by ELISA, although most of their antigens were sensitive to chymopapain digestion. DNA sequences from ten positive clones showed that they were from four different clones. They bound antigens with different molecular weight.
CONCLUSIONSOne hundred and two scFv phage clones specific for hematopoietic stem and progenitor cells have been isolated from an anti-KG1a cell scFv phage library. The pathfinder selection has showed advantages to improve the screening efficacy of scFv phage clones against antigens, which present at very low densities on the cell surface.
Antibodies, Anti-Idiotypic ; immunology ; Antibodies, Monoclonal ; genetics ; Antibody Specificity ; Bacteriophages ; genetics ; Cloning, Molecular ; Hematopoietic Stem Cells ; immunology ; Humans ; Immunoglobulin Fc Fragments ; biosynthesis ; genetics ; immunology ; Immunoglobulin Fragments ; genetics ; immunology ; Immunoglobulin Variable Region ; genetics ; immunology ; Peptide Library ; Single-Chain Antibodies
6.Soluble expression and characterization of disulfide bond-rich subdomains of membrane protein p185 in Escherichia coli.
Liang-Wei LI ; Hai-Bo LIU ; Si-Yi HU ; Dun LIANG ; Lian-Sheng CHENG ; Jing LIU
Chinese Journal of Biotechnology 2005;21(4):590-596
Transmembrane protein p185 (the product of Her2/c-erbB-2 gene) is a member of the epidermal growth factor receptor (EGFR) family. Its overexpression was found in about 30% of breast cancer. It is essential to obtain soluble extracellular domain (ECD) of p185, especially disulfide bond rich domains, for identifying the epitopes of anti-p185 antibodies and researching the interrelationship between the antigen and antibody. The disulfide bond rich domain I-II and domain IV of p185 ECD were amplified from plasmid pBabe/erbB-2 by PCR respectively. These two fragments were inserted into pGEX/4T-1 vector, transfected into E. coli Origami B (DE3) pLysS and expressed inductively by low concentration of IPTG and low temperature overnight. After the pressure lysis of cells, the supernatants were analyzed by SDS-PAGE and the result demonstrated that this GST-fusion protein was expressed solubly in the amount of 10-15 mg/L. By the ELISA, Western blot and other immunological assays, the fusion proteins and their GST cut-off derivates both showed binding activities with several anti-p185 antibodies respectively. These results indicated that it was a feasible and effectual method to express disulfide bond rich domain I-II and domain IV of p185 ECD and this method may also be used to express other disulfide bond rich proteins.
Antibodies, Monoclonal
;
immunology
;
Disulfides
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Genetic Vectors
;
genetics
;
Humans
;
Receptor, ErbB-2
;
biosynthesis
;
genetics
;
immunology
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
;
Solubility
;
Transfection
7.Expression and renaturation of a novel human single-chain Fv antibody against SARS-CoV.
Jin-Zhu DUAN ; Cai QI ; Wei HAN ; Zhan-Hui WANG ; Gang JIN ; Xi-Yun YAN
Chinese Journal of Biotechnology 2005;21(5):692-697
A novel human ScFv H12 against SARS-CoV has been selected from a SARS immune library. In order to produce a large amount of ScFv H12, pET28a-H12 expression vector was constructed and ScFv H12 was expressed at yield about 30% of total proteins in E. coli . Here two different refolding procedures were used to refold ScFv H12 from inclusion body: gel filtration chromatography and dilution. The results showed that ScFv H12 could be efficiently refolded by both procedures. However, the refolding via gel filtration was 1.5 time more effective than that of dilution. The affinity of ScFv H12 to SARS-CoV virion was detected as Kd = 73.5 nmol/mL.
Antibodies, Monoclonal
;
biosynthesis
;
genetics
;
Antibodies, Viral
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Humans
;
Immunoglobulin Fragments
;
biosynthesis
;
genetics
;
immunology
;
Immunoglobulin Variable Region
;
biosynthesis
;
genetics
;
immunology
;
Inclusion Bodies
;
genetics
;
immunology
;
Protein Renaturation
;
Recombinant Proteins
;
biosynthesis
;
chemistry
;
immunology
;
SARS Virus
;
immunology
8.Progress in preparation of small monoclonal antibodies of knock out technique.
Jing LIU ; Xin-min MAO ; Lin-lin LI ; Xin-xia LI ; Ye WANG ; Yi LAN
China Journal of Chinese Materia Medica 2015;40(19):3737-3741
With the application of monoclonal antibody technology more and more widely, its production technology is becoming more and more perfect. Small molecule monoclonal antibody technology is becoming a hot research topic for people. The application of traditional Chinese medicine small molecule monoclonal antibody technology has been more and more widely, the technology for effective Chinese medicine component knockout provide strong technical support. The preparation of monoclonal antibodies and small molecule knockout technology are reviewed in this paper. The preparation of several steps, such as: in the process of preparation of antigen, hapten carrier coupling, coupling ratio determination and identification of artificial antigen and establishment of animal immunization and hybridoma cell lines of monoclonal antibody, the large-scale preparation; small molecule monoclonal antibody on Immune in affinity chromatography column method is discussed in detail. The author believes that this technology will make the traditional Chinese medicine research on a higher level, and improve the level of internationalization of Chinese medicine research.
Animals
;
Antibodies, Monoclonal
;
chemistry
;
genetics
;
immunology
;
Humans
;
Hybridomas
;
metabolism
;
Immunologic Techniques
;
methods
;
trends
9.Generation and epitope mapping of a monoclonal antibody against nucleoprotein of Ebola virus.
Xiaodu WANG ; Yang LIU ; Haoting WANG ; Zixue SHI ; Fanfan ZHAO ; Jianchao WEI ; Donghua SHAO ; Zhiyong MA
Chinese Journal of Biotechnology 2012;28(11):1317-1327
Ebola virus (EBOV) causes highly lethal hemorrhagic fever in humans and nonhuman primates and has a significant impact on public health. The nucleoprotein (NP) of EBOV (EBOV-NP) plays a central role in virus replication and has been used as a target molecule for disease diagnosis. In this study, we generated a monoclonal antibody (MAb) against EBOV-NP and mapped the epitope motif required for recognition by the MAb. The MAb generated via immunization of mice with prokaryotically expressed recombinant NP of the Zaire Ebola virus (ZEBOV-NP) was specific to ZEBOV-NP and able to recognize ZEBOV-NP expressed in prokaryotic and eukaryotic cells. The MAb cross-reacted with the NP of the Reston Ebola virus (REBOV), the Cote-d'Ivoire Ebola virus (CIEBOV) and the Bundibugyo Ebola virus (BEBOV) but not with the NP of the Sudan Ebola virus (SEBOV) or the Marburg virus (MARV). The minimal epitope sequence required for recognition by the MAb was the motif PPLESD, which is located between amino acid residues 583 and 588 at the C-terminus of ZEBOV-NP and well conserved among all 16 strains of ZEBOV, CIEBOV and BEBOV deposited in GenBank. The epitope motif is conserved in four out of five strains of REBOV.
Animals
;
Antibodies, Monoclonal
;
immunology
;
Ebolavirus
;
chemistry
;
immunology
;
Epitope Mapping
;
methods
;
Escherichia coli
;
genetics
;
metabolism
;
Mice
;
Mice, Inbred BALB C
;
Nucleoproteins
;
immunology
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
10.Molecular mechanism of an individual with weaken B phenotype in ABO blood group.
Yan-ling YING ; Su-dan TAO ; Yan-min HE ; Xian-guo XU ; Fa-ming ZHU ; Hang-jun LV ; Li-xing YAN
Chinese Journal of Medical Genetics 2011;28(4):397-400
OBJECTIVETo elucidate the serological characteristics and molecular mechanism of a blood donor with weaken B antigen.
METHODSThe ABO blood group antigens on red blood cells were identified by monoclonal antibodies, the ABO antibodies in serum were detected by standard A, B, O cells and the activity of the B glycosyltransferase was analyzed. The full-length sequence and 5'-untranslated region (5'-UTR) sequence of ABO gene were amplified by polymerase chain reaction (PCR) respectively and direct sequencing. The alternative splicing isoforms of ABO cDNA were obtained by reverse transcription-PCR(RT-PCR) and analyzed with cloning and sequencing techniques. The level of methylation of the CpG island in ABO gene promoter was analyzed by bisulfite sequencing method.
RESULTSThe serological characteristic of the donor showed that the B antigen was decreased obviously without anti-B antibodies in serum and the B glycosyltransferase activity was decreased as well. The genotype of the donor was B101/O01 without any other mutations in the full-length coding sequences and splice receptor sites. The nucleotide characteristics of the 5'-UTR was consistent with B101/O01 and no any abnormity was identified in the promoter, enhancer and the negative regulatory sequence regions. The integrative cDNA transcript of ABO gene was obtained and no new splicing isoform was found. Compared with the normal B phenotype, a number of methylated CpG sites were found near the promoter of ABO gene in this sample.
CONCLUSIONThe methylation in the CpG island of ABO gene promoter region may cause weak expression of the B antigen.
ABO Blood-Group System ; genetics ; immunology ; Alleles ; Antibodies, Monoclonal ; immunology ; Blood Donors ; CpG Islands ; genetics ; Erythrocytes ; immunology ; Gene Expression Regulation ; immunology ; Humans ; Phenotype ; Reverse Transcriptase Polymerase Chain Reaction